Axonics Inc (NASDAQ:AXNX)
| 72.28 Delayed Data As of 4:00pm ET |  +2.20 / +3.14%Today’s Change | 38.41 Today|||52-Week Range 79.81 | +29.07% Year-to-Date |
Latest AXNX News | Press Releases
| Here's Why Axonics Modulation Technologies (AXNX) is a Great Momentum Stock to Buy Aug 08 / Zacks.com - Paid Partner Content | Axonics Modulation Technologies (AXNX) Reports Q2 Loss, Tops Revenue Estimates Aug 01 / Zacks.com - Paid Partner Content |
| Is Axonics (AXNX) Stock Outpacing Its Medical Peers This Year? Aug 04 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 70.08 |
| Today’s open | 70.42 |
| Day’s range | 69.63 - 72.41 |
| Volume | 21,535 |
| Average volume (3 months) | 599,608 |
| Market cap | $3.3B |
Data as of 4:00pm ET, 08/12/2022
Growth & Valuation
| Earnings growth (last year) | -25.19% |
| Earnings growth (this year) | +2.24% |
| Earnings growth (next 5 years) | +43.00% |
| Revenue growth (last year) | +61.64% |
| P/E ratio | NM |
| Price/Sales | 13.38 |
| Price/Book | 6.82 |
Competitors
Data as of 4:00pm ET, 08/12/2022
Financials
| Next reporting date | December 13, 2022 |
| EPS forecast (this quarter) | -$0.47 |
| Annual revenue (last year) | $180.3M |
| Annual profit (last year) | -$80.1M |
| Net profit margin | -44.41% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
